Clinical Study
Jumihaidokuto (Shi-Wei-Ba-Du-Tang), a Kampo Formula, Decreases the Disease Activity of Palmoplantar Pustulosis
Table 1
Characteristics and evaluation of clinical symptoms in patients treated with JHT.
| Case | Age (y) | Sex | Prescribed medications | Period (weeks) | PPPASI (before treatment) | PPPASI (after treatment) | PPPASI improvement (%) |
| 1 | 59 | Female | Topical corticosteroid, oral antihistamine, oral vitamin H | 6 | 31 | 24.2 | 21.9 |
| 2 | 61 | Female | Topical corticosteroid, topical vitamin D3 | 6 | 6.2 | 3.6 | 41.9 |
| 3 | 66 | Male | Topical corticosteroid, topical vitamin D3 | 8 | 7.2 | 5.4 | 25 |
| 4 | 73 | Female | Topical corticosteroid, oral antihistamine, oral vitamin H | 4 | 4.8 | 2.8 | 41.7 |
| 5 | 66 | Female | Topical corticosteroid, topical vitamin D3 | 8 | 7.8 | 4.4 | 43.6 |
| 6 | 63 | Male | Topical corticosteroid, oral antihistamine, oral vitamin H | 8 | 14.8 | 8.8 | 40.5 |
| 7 | 63 | Male | Topical corticosteroid, oral antihistamine | 4 | 8 | 1.2 | 85 |
| 8 | 77 | Male | Topical corticosteroid, oral vitamin H | 8 | 1.2 | 1.2 | 0 |
| 9 | 70 | Female | Topical corticosteroid, oral vitamin H | 5 | 0.4 | 0.4 | 0 |
| 10 | 59 | Female | Topical corticosteroid, oral antihistamine, oral vitamin H | 4 | 2 | 2.6 | ā30 |
|
|